RxDoctor Payments Data

Ali Khalifeh, MD

Vascular Surgery · Rochester, MNNPI 1083057210

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (44.9%), grants and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Medtronic at 49.8% of the total. Reporting peaked in 2020 at $2,016 and has fallen 72.3% since, to $558 in 2025.

$5,031in general payments, 2019–2025

Across 44 payments — averaging $114.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • W. L. Gore & Associates, Inc.$1K
  • Penumbra, Inc.$313
  • Terumo Medical Corporation$164
  • Cook Incorporated$141
  • Bolton Medical Inc$119
  • plus $387 from 8 others
$13,370in research payments, 2019–2025

Across 5 payments — averaging $2674.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • M.a. Med Alliance S.A.$13K

What the payments were for

  • Grants$2,01640%
  • Travel & lodging$56611%
  • Food & beverage$2,25845%
  • Education$1914%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,031 in reported general payments places this provider in the 65th percentile of 84 vascular surgery providers in Minnesota.

See all vascular surgery providers in Minnesota

Medicare billing

Part B allowed, 2024
$104,177
Medicare patients
477
Services billed
955

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular surgery in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →